EZH2 and breast carcinoma: Within the breast cancer microenvironment, tumor-associated macrophages (TAMs) secrete the IL-6 cytokine, which triggers PRMT1 to mediate the formation of asymmetric dimethylation of EZH2 at arginine 342 [44].